VALLEY COTTAGE, New York, July 31, 2017 /PRNewswire/ --
North America is projectedto remain dominant in the global MRI-compatible IV infusion pump system market, according to a report by Future Market Insights (FMI). In North America, there is a surge in demand for advanced IV infusion pump
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
Market in North America is projected to expand at 13.6% CAGR, to reach nearly US$ 200 Mn in revenues by 2027-end. North American government is offering favourable reimbursement policies for infusion therapies, further boosting the market growth in this region. However, increasing product recalls on the back of safety concerns and design deficiencies are expected to hamper growth of the MRI-compatible IV infusion pump system market in North America.
Request a Sample Report with Table of Contents and Figures: http://www.futuremarketinsights.com/reports/sample/rep-gb-3525
Higher Adoption of Non-Magnetic MRI-Compatible IV Infusion Pump System to Fuel Market Growth in Western Europe
Western Europe is expected to be second-most lucrative region in the global MRI-compatible IV infusion pump system market by 2027-end. European healthcare providers are highly focusing on adoption of non-magnetic MRI-compatible IV infusion pump system, to avoid occupational risks and follow safety concerns. This has led to a considerable growth of the market in this region.
In addition, other factors such as increasing hospitalisations, and rising incidences of cancer have led to growing demand for MRI diagnosis in Western Europe. This is further expected to drive demand for MRI-compatible IV infusion pump systems in this region. However, stringent rules & regulation imposed by European Commission on new product launches, and their marketing & sales activities are expected to impede growth of the market in Western Europe.
Revenue from Global Sales of MRI-Compatible IV Infusion Pump System to Reach US$ 138.1 Mn in 2017
FMI's report estimates the global MRI-compatible IV infusion pump system market to register a robust expansion at 11.2 % CAGR through 2027. Global sales of MRI-compatible IV infusion pump system will account for revenues worth US$ 138.1 Mn in 2017; by 2027 this number is estimated to reach nearly US$ 400 Mn. The market is projected to represent an incremental opportunity of US$ 260.5 Mn between 2017 and 2027.
Preview Analysis on Global MRI - Compatible IV Infusion Pump Systems Market Segmentation Product Type - Devices Type (Non-magnetic Pump System, Magnetic Pump System with Shielding), Tubing and Disposables; End User - Hospitals, Ambulatory Surgical Centres, Diagnostics and Imaging Centres: http://www.futuremarketinsights.com/reports/mri-compatible-iv-infusion-pump-systems-market
Hospitals will remain the largest end-users of MRI-compatible IV infusion pump system globally. Sales of MRI-compatible IV infusion pump system in hospitals are expected to reach nearly US$ 300 Mn by 2027-end. In addition, diagnostics & imaging centres and ambulatory surgical centres are expected to exhibit 8.2% and 7.7% CAGRs respectively in the market through 2027.
Magnetic Pump System with Shielding to Remain Preferred Device in the Market
Based on product type, devices for MRI-compatible IV infusion pump system will remain dominant in the global market, expanding at 11.6% CAGR through 2027. Magnetic pump system with shielding will remain preferred device in the market, with sales poised to surpass US$ 200 Mn by 2027-end. Sales of tubing & disposables required for MRI-compatible IV infusion pump system are anticipated to register a comparatively low CAGR in the market.
Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: http://www.futuremarketinsights.com/askus/rep-gb-3525
Key market players identified in FMI's report include iRadimed Corporation, B.Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical (Smiths Group plc.), Arcomed AG, Becton, Dickinson Company (Carefusion), Baxter International Inc.
More from FMI's Cutting-edge Intelligence:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: [email protected] Press Office: [email protected]
Find Market Research: http://www.findmarketresearch.org/
SOURCE Future Market Insights
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All